This report was first published by Endpoints News. To see the original version, click here
Earlier this month, a new cancer drug captivated patients and investors.
Now the lawyers get their turn.
您已阅读8%（193字），剩余92%（2141字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。